TACC3 as an independent prognostic marker for solid tumors: a systematic review and meta-analysis
- PMID: 29088887
- PMCID: PMC5650442
- DOI: 10.18632/oncotarget.20466
TACC3 as an independent prognostic marker for solid tumors: a systematic review and meta-analysis
Abstract
Recent studies have showed that the transforming acidic coiled coil 3 (TACC3), was aberrantly up-regulated in various solid tumors and was reported to be correlated with unfavorable prognosis in cancer patients. This study aimed to examine the relationship between TACC3 and relevant clinical outcomes. Pubmed, Web of Science, Embase and Cochrane Library were systematically searched to obtain all eligible articles. Pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated to evaluate the influence of TACC3 expression on overall survival (OS) and disease-free survival (DFS) in solid tumors patients. A total of 1943 patients from 11 articles were included. The result indicated that a significantly shorter OS was observed in patients with high expression level of TACC3 (HR=1.90, 95% CI=1.63-2.23). In the subgroup analysis, the association was also observed in patients with cancers of digestive system (HR=1.85, 95% CI=1.53-2.24). Statistical significance was also observed in subgroup meta-analysis stratified by the cancer type, analysis type and sample size. Furthermore, poorer DFS was observed in patients with high expression level of TACC3 (HR=2.67, 95% CI=2.10-3.40). Additionally, the pooled odds ratios (ORs) showed that increased TACC3 expression was also related to positive lymph node metastasis (OR=1.68, 95% CI=1.26-2.25), tumor differentiation (OR=1.90, 95% CI=1.25-2.88) and TNM stage (OR=1.66, 95% CI=1.25-2.20). In conclusion, the increased expression level of TACC3 was associated with unfavorable prognosis, suggesting that it was a valuable prognosis biomarker or a promising therapeutic target of solid tumors. Further studies should be conducted to confirm the clinical utility of TACC3 in human solid tumors.
Keywords: TACC3; meta-analysis; prognosis; solid tumors; survival.
Figures
Similar articles
-
The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.PLoS One. 2016 Apr 1;11(4):e0152674. doi: 10.1371/journal.pone.0152674. eCollection 2016. PLoS One. 2016. PMID: 27035914 Free PMC article.
-
Prognostic value of long non-coding RNA UCA1 in human solid tumors.Oncotarget. 2016 Sep 6;7(36):57991-58000. doi: 10.18632/oncotarget.11155. Oncotarget. 2016. PMID: 27517147 Free PMC article.
-
Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.Pathol Res Pract. 2019 Sep;215(9):152449. doi: 10.1016/j.prp.2019.152449. Epub 2019 Jun 8. Pathol Res Pract. 2019. PMID: 31378453
-
The prognostic value of HOXA13 in solid tumors: A meta-analysis.Clin Chim Acta. 2018 Aug;483:64-68. doi: 10.1016/j.cca.2018.04.024. Epub 2018 Apr 17. Clin Chim Acta. 2018. PMID: 29678634 Review.
-
Tetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysis.Oncotarget. 2017 Jan 17;8(3):5592-5602. doi: 10.18632/oncotarget.13532. Oncotarget. 2017. PMID: 27888619 Free PMC article. Review.
Cited by
-
ZY-444 inhibits the growth and metastasis of prostate cancer by targeting TNFAIP3 through TNF signaling pathway.Am J Cancer Res. 2023 Apr 15;13(4):1533-1546. eCollection 2023. Am J Cancer Res. 2023. PMID: 37168345 Free PMC article.
-
E2F1 promotes cell cycle progression by stabilizing spindle fiber in colorectal cancer cells.Cell Mol Biol Lett. 2022 Oct 11;27(1):90. doi: 10.1186/s11658-022-00392-y. Cell Mol Biol Lett. 2022. PMID: 36221072 Free PMC article.
-
The prognostic activity of transforming acidic coiled-coil 3 (TACC3) immunohistochemical expression in colon adenocarcinoma patients.Prz Gastroenterol. 2022;17(3):227-233. doi: 10.5114/pg.2022.118469. Epub 2022 Aug 5. Prz Gastroenterol. 2022. PMID: 36127940 Free PMC article.
-
RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC.Sci Rep. 2022 Jan 20;12(1):1049. doi: 10.1038/s41598-022-05013-4. Sci Rep. 2022. PMID: 35058503 Free PMC article.
-
A Novel Nine-Gene Signature Associated With Immune Infiltration for Predicting Prognosis in Hepatocellular Carcinoma.Front Genet. 2021 Nov 30;12:730732. doi: 10.3389/fgene.2021.730732. eCollection 2021. Front Genet. 2021. PMID: 34917126 Free PMC article.
References
-
- Devassy JG, Nwachukwu ID, Jones PJ. Curcumin and cancer: barriers to obtaining a health claim. Nutr Rev. 2015;73:155–165. - PubMed
-
- Gonzalez CA, Agudo A. Carcinogenesis, prevention and early detection of gastric cancer: where we are and where we should go. Int J Cancer. 2012;130:745–753. - PubMed
-
- McKeveney PJ, Hodges VM, Mullan RN, Maxwell P, Simpson D, Thompson A, Winter PC, Lappin TR, Maxwell AP. Characterization and localization of expression of an erythropoietin-induced gene, ERIC-1/TACC3, identified in erythroid precursor cells. Br J Haematol. 2001;112:1016–1024. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
